Augment Bone Graft
NDA- Indications
- Foot and ankle fusion, Hindfoot fusion
Company intelligence / Profile preview
BioMimetic Therapeutics
Franklin, Tennessee, United Statesdnb.com ↗
- Ownership
- Private
- Development stage
- NDA
01
Overview
The company developed protein-based regenerative therapies with a focus on musculoskeletal healing. Its lead product Augment Bone Graft received regulatory approvals outside the US and was under FDA review at time of acquisition. Clinical programs included injectable formulations for tendon injuries with promising preclinical data advancing to Phase II trials as of early 2013.[5][6]
- Therapeutic areas
- OtherNeurologyRheumatology
- Modalities
- Protein therapeutics (recombinant human platelet-derived growth factor BB - rhPDGF-BB)[1][2][6]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed; investors include Novo Holdings, Burrill & Company among others [1].
Beyond the preview
Go deeper on BioMimetic Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioMimetic Therapeutics.